128 related articles for article (PubMed ID: 21051861)
1. Smaddening complexity: the role of Smad3 in epithelial-myofibroblast transition.
Masszi A; Kapus A
Cells Tissues Organs; 2011; 193(1-2):41-52. PubMed ID: 21051861
[TBL] [Abstract][Full Text] [Related]
2. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells.
Bae E; Kim SJ; Hong S; Liu F; Ooshima A
Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526
[TBL] [Abstract][Full Text] [Related]
3. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.
Patel P; West-Mays J; Kolb M; Rodrigues JC; Hoff CM; Margetts PJ
Matrix Biol; 2010 Mar; 29(2):97-106. PubMed ID: 19896531
[TBL] [Abstract][Full Text] [Related]
4. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
Guarino M; Tosoni A; Nebuloni M
Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
[TBL] [Abstract][Full Text] [Related]
5. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells.
Cho HJ; Yoo J
Cell Biol Int; 2007 Oct; 31(10):1225-30. PubMed ID: 17537651
[TBL] [Abstract][Full Text] [Related]
6. Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro.
Lv ZD; Na D; Ma XY; Zhao C; Zhao WJ; Xu HM
Int J Mol Med; 2011 Feb; 27(2):187-93. PubMed ID: 21152863
[TBL] [Abstract][Full Text] [Related]
7. Differential topical susceptibility to TGFβ in intact and injured regions of the epithelium: key role in myofibroblast transition.
Speight P; Nakano H; Kelley TJ; Hinz B; Kapus A
Mol Biol Cell; 2013 Nov; 24(21):3326-36. PubMed ID: 24006486
[TBL] [Abstract][Full Text] [Related]
8. β-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition.
Charbonney E; Speight P; Masszi A; Nakano H; Kapus A
Mol Biol Cell; 2011 Dec; 22(23):4472-85. PubMed ID: 21965288
[TBL] [Abstract][Full Text] [Related]
9. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
10. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3.
Masszi A; Speight P; Charbonney E; Lodyga M; Nakano H; Szászi K; Kapus A
J Cell Biol; 2010 Feb; 188(3):383-99. PubMed ID: 20123992
[TBL] [Abstract][Full Text] [Related]
11. LIM-domain proteins in transforming growth factor β-induced epithelial-to-mesenchymal transition and myofibroblast differentiation.
Järvinen PM; Laiho M
Cell Signal; 2012 Apr; 24(4):819-25. PubMed ID: 22182513
[TBL] [Abstract][Full Text] [Related]
12. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology.
Burns WC; Thomas MC
Expert Rev Mol Med; 2010 May; 12():e17. PubMed ID: 20504380
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
14. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
Dzwonek J; Preobrazhenska O; Cazzola S; Conidi A; Schellens A; van Dinther M; Stubbs A; Klippel A; Huylebroeck D; ten Dijke P; Verschueren K
Mol Cancer Res; 2009 Aug; 7(8):1342-53. PubMed ID: 19671686
[TBL] [Abstract][Full Text] [Related]
15. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.
Roberts AB; Tian F; Byfield SD; Stuelten C; Ooshima A; Saika S; Flanders KC
Cytokine Growth Factor Rev; 2006; 17(1-2):19-27. PubMed ID: 16290023
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.
Bagchi RA; Roche P; Aroutiounova N; Espira L; Abrenica B; Schweitzer R; Czubryt MP
BMC Biol; 2016 Mar; 14():21. PubMed ID: 26988708
[TBL] [Abstract][Full Text] [Related]
17. Regulators and mediators of radiation-induced fibrosis: Gene expression profiles and a rationale for Smad3 inhibition.
Lee JW; Zoumalan RA; Valenzuela CD; Nguyen PD; Tutela JP; Roman BR; Warren SM; Saadeh PB
Otolaryngol Head Neck Surg; 2010 Oct; 143(4):525-30. PubMed ID: 20869563
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
19. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Brown KA; Pietenpol JA; Moses HL
J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
[TBL] [Abstract][Full Text] [Related]
20. [The mechanism of transforming growth factor beta1 in myofibroblast differentiation].
Liu HX; Wang SW; Zhao CH; Liu Y; Li Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):986-9. PubMed ID: 17961388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
